The one-shot vaccine from Johnson & Johnson is on track to become the third allowed for use in the U.S. following Friday’s recommendation by a key advisory committee. The Food and Drug Administration is expected to authorize it within days, and doses could begin rolling out to the American public next week. | |
News Alert Friday, February 26 |
|
| | | | |
|